Log In
Print this Print this

Fortesta, Fortigel, Itnogen, Tostran, testosterone

Also known as: Tostrex

  Manage Alerts
Collapse Summary General Information
Company Kyowa Hakko Kirin Co. Ltd.
DescriptionTransdermal 2% testosterone gel
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypogonadism
Indication DetailsTreat hypogonadism in cancer patients; Treat symptoms of male hypogonadism; Treat symptoms of male hypogonadism in patients with Type II diabetes and/or metabolic syndrome
Regulatory Designation
Partner Bayer AG; Endo International plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today